证券时报·2026-01-07 04:12Core Viewpoint - The capital market in Tibet has made significant contributions to the high-quality development of the local economy during the "14th Five-Year Plan" period, with a focus on the dual growth of quantity and quality of listed companies, continuous innovation investment, improved investor return mechanisms, and robust risk prevention measures [1][2]. Group 1: Listed Companies' Performance - During the "14th Five-Year Plan," the number of listed companies in Tibet increased to 22, with a total market value rising from over 200 billion to 320 billion yuan, and 14 companies entering the "100 billion club," accounting for nearly 60% [7]. - The total operating revenue of these companies reached 40.98 billion yuan in the first three quarters of 2025, a year-on-year increase of 4.96%, while net profit attributable to shareholders was 6.63 billion yuan, up 37.2%, significantly outpacing national averages [7]. - The pharmaceutical and non-ferrous metal industries have emerged as the main drivers of regional economic development, with 8 pharmaceutical companies and 3 non-ferrous metal companies leading the way [7]. Group 2: Innovation and R&D - Innovation has been a core strategy for listed companies in Tibet, with R&D expenditures reaching 2.206 billion yuan in 2024, a 53.09% increase from 1.441 billion yuan in 2020, and R&D intensity rising to 4.06%, exceeding the national average by about 2 percentage points [12]. - In the first three quarters of 2025, R&D expenses totaled 1.74 billion yuan, a year-on-year increase of 18.8%, with R&D intensity reaching 4.24, nearly double the national average [12]. Group 3: Investor Returns - Listed companies in Tibet have focused on enhancing investor returns, with cumulative cash dividends during the "14th Five-Year Plan" period amounting to 17.012 billion yuan, a 28.79% increase compared to the "13th Five-Year Plan" [14]. - The stability and predictability of dividends have improved significantly, with companies like Meihua Biological achieving the highest cumulative dividends of 6.218 billion yuan during this period [14][15]. Group 4: Financing and Capital Tools - The capital market in Tibet has diversified financing tools, with direct financing amounts growing from 13.92 billion yuan in 2021 to 25.528 billion yuan in 2024, reflecting a compound annual growth rate of 22.40% [16]. - The issuance of asset-backed securities (ABS) marked a significant milestone, with a local state-owned enterprise issuing 7 ABS products in 2024, achieving a "zero breakthrough" in ABS issuance in Tibet [16]. Group 5: Risk Prevention and Regulation - Regulatory authorities in Tibet have adopted a "zero tolerance" approach to risk prevention, handling 13 cases of capital market violations during the "14th Five-Year Plan," with penalties exceeding 30 million yuan [19]. - The region has maintained a "zero default" status for corporate bonds, with no companies facing delisting risks during this period [19]. Group 6: Future Outlook - Looking ahead to the "15th Five-Year Plan," the capital market in Tibet aims to empower regional economic development through innovation, industrial upgrades, and risk prevention, with a focus on nurturing quality enterprises in sectors like pharmaceuticals and new materials [22].